Dimensional Fund Advisors’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$99.2M Buy
2,582,375
+1,588
+0.1% +$61K 0.02% 1017
2025
Q1
$100M Sell
2,580,787
-17,783
-0.7% -$689K 0.02% 978
2024
Q4
$87.9M Buy
2,598,570
+18,492
+0.7% +$625K 0.02% 1140
2024
Q3
$105M Buy
2,580,078
+323,758
+14% +$13.2M 0.03% 989
2024
Q2
$86.9M Buy
2,256,320
+569,614
+34% +$21.9M 0.02% 1072
2024
Q1
$72.3M Sell
1,686,706
-90,989
-5% -$3.9M 0.02% 1211
2023
Q4
$65.9M Buy
1,777,695
+18,585
+1% +$689K 0.02% 1239
2023
Q3
$63.8M Buy
1,759,110
+58,225
+3% +$2.11M 0.02% 1162
2023
Q2
$60.6M Buy
1,700,885
+175,731
+12% +$6.26M 0.02% 1220
2023
Q1
$54.3M Sell
1,525,154
-14,338
-0.9% -$510K 0.02% 1256
2022
Q4
$54.1K Sell
1,539,492
-323,313
-17% -$11.4K 0.02% 1259
2022
Q3
$54.8M Sell
1,862,805
-3,357
-0.2% -$98.8K 0.02% 1151
2022
Q2
$102M Buy
1,866,162
+1,396
+0.1% +$76K 0.04% 723
2022
Q1
$102M Sell
1,864,766
-2,903
-0.2% -$158K 0.03% 841
2021
Q4
$103M Buy
1,867,669
+2,804
+0.2% +$155K 0.03% 861
2021
Q3
$89.1M Sell
1,864,865
-42,347
-2% -$2.02M 0.03% 933
2021
Q2
$94.9M Sell
1,907,212
-61,157
-3% -$3.04M 0.03% 897
2021
Q1
$87.8M Sell
1,968,369
-2,464
-0.1% -$110K 0.03% 937
2020
Q4
$90.7M Sell
1,970,833
-250,087
-11% -$11.5M 0.03% 829
2020
Q3
$104M Sell
2,220,920
-322,330
-13% -$15.2M 0.04% 548
2020
Q2
$130M Sell
2,543,250
-2,300
-0.1% -$117K 0.06% 381
2020
Q1
$121M Buy
2,545,550
+380,392
+18% +$18M 0.06% 298
2019
Q4
$127M Buy
2,165,158
+159,670
+8% +$9.38M 0.05% 549
2019
Q3
$107M Buy
2,005,488
+134,449
+7% +$7.17M 0.04% 626
2019
Q2
$93.6M Buy
1,871,039
+218,617
+13% +$10.9M 0.04% 750
2019
Q1
$86.3M Buy
1,652,422
+236,535
+17% +$12.4M 0.03% 802
2018
Q4
$67.6M Buy
1,415,887
+70,518
+5% +$3.37M 0.03% 915
2018
Q3
$67.6M Buy
1,345,369
+32,825
+3% +$1.65M 0.03% 1106
2018
Q2
$66.1M Sell
1,312,544
-25,156
-2% -$1.27M 0.03% 1082
2018
Q1
$65.3M Buy
1,337,700
+54,849
+4% +$2.68M 0.03% 1028
2017
Q4
$56.9M Buy
1,282,851
+4,161
+0.3% +$184K 0.02% 1209
2017
Q3
$64.9M Buy
1,278,690
+4,607
+0.4% +$234K 0.03% 990
2017
Q2
$68.7M Buy
1,274,083
+105,027
+9% +$5.66M 0.03% 865
2017
Q1
$61.6M Buy
1,169,056
+7,982
+0.7% +$421K 0.03% 932
2016
Q4
$55.9M Buy
1,161,074
+23,552
+2% +$1.13M 0.03% 1014
2016
Q3
$61.3M Buy
1,137,522
+39,397
+4% +$2.12M 0.03% 830
2016
Q2
$59.5M Buy
1,098,125
+34,915
+3% +$1.89M 0.03% 785
2016
Q1
$53.9M Buy
1,063,210
+59,196
+6% +$3M 0.03% 834
2015
Q4
$50.6M Buy
1,004,014
+47,484
+5% +$2.39M 0.03% 841
2015
Q3
$46M Buy
956,530
+1,320
+0.1% +$63.4K 0.03% 881
2015
Q2
$49.7M Buy
955,210
+5,924
+0.6% +$308K 0.03% 868
2015
Q1
$54.8M Buy
949,286
+65,300
+7% +$3.77M 0.03% 748
2014
Q4
$47.2M Buy
883,986
+101,678
+13% +$5.43M 0.03% 819
2014
Q3
$45M Buy
782,308
+45,822
+6% +$2.63M 0.03% 777
2014
Q2
$49.2M Buy
736,486
+29,531
+4% +$1.97M 0.03% 720
2014
Q1
$47.2M Buy
706,955
+182,650
+35% +$12.2M 0.04% 693
2013
Q4
$35M Buy
524,305
+62,031
+13% +$4.14M 0.03% 916
2013
Q3
$29M Buy
462,274
+98,826
+27% +$6.2M 0.03% 995
2013
Q2
$22.7M Buy
+363,448
New +$22.7M 0.02% 1134